FDA 执法报告 D-0788-2026:Fresenius Kabi 因标签混淆召回 Morphine Sulfate 注射液,列为 Class I
FDA drug enforcement D-0788-2026: Fresenius Kabi USA, LLC — Labeling: Label Mixup: MicroVault labeled as Morphine 2 mg/1 mL, contains a Prefilled Syringe of Dilaudid 0.5 mg/0.5 mL.
FDA 执法报告 D-0788-2026 将 Fresenius Kabi USA 自愿召回的 Morphine Sulfate 注射液(USP,2 mg/mL,1 mL 单剂量预充式注射器)列为 Class I。
记录显示该召回列为 Class I 且仍在进行,可核对标签混淆涉及的产品、批次与分销范围。
FDA drug recall enforcement report — D-0788-2026
Report issued: 2026-08-26. This is the enforcement report date, not the recall initiation date.
Scope: one classified drug product recall record; event_id may group multiple products. Unclassified records without recall numbers are outside this stream. This record is not a press release or a new enforcement finding.
The openFDA dataset is updated weekly. Report status is not a live recall status and must not be used to track the recall lifecycle. Other dates below retain their named meanings.
Complete official product record (including openFDA harmonized identifiers):
{
"address_1": "3 Corporate Dr",
"address_2": "",
"center_classification_date": "20260824",
"city": "Lake Zurich",
"classification": "Class I",
"code_info": "Lot #: 6402820, Exp. Date 12/2028",
"country": "United States",
"distribution_pattern": "Nationwide within the USA.",
"event_id": "99533",
"initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit",
"more_code_info": "",
"openfda": {
"application_number": [
"NDA204223"
],
"brand_name": [
"MORPHINE SULFATE"
],
"generic_name": [
"MORPHINE SULFATE"
],
"is_original_packager": [
true
],
"manufacturer_name": [
"Fresenius Kabi, USA LLC"
],
"package_ndc": [
"76045-238-01",
"76045-238-10",
"76045-004-01",
"76045-004-11",
"76045-005-01",
"76045-005-11",
"76045-006-01",
"76045-006-11",
"76045-007-01",
"76045-007-11",
"76045-008-01",
"76045-008-11"
],
"product_ndc": [
"76045-238",
"76045-004",
"76045-005",
"76045-006",
"76045-007",
"76045-008"
],
"product_type": [
"HUMAN PRESCRIPTION DRUG"
],
"route": [
"INTRAMUSCULAR",
"INTRAVENOUS"
],
"rxcui": [
"894912",
"894914",
"998212",
"998213",
"1442790",
"2752697"
],
"spl_id": [
"e61f6eb4-cc71-47d3-b2f6-5e689c773779"
],
"spl_set_id": [
"1f53de80-efc8-4930-b3e3-fba0d026af05"
],
"substance_name": [
"MORPHINE SULFATE"
],
"unii": [
"X3P646A2J0"
]
},
"postal_code": "60047-8930",
"product_description": "Morphine Sulfate Injection, USP, 2 mg /mL, 1 mL single-dose Simplist prefilled syringes, For Intramuscular or Intravenous use, Rx only, Fresenius Kabi, Lake Zurich, IL. Unit of Use NDC Number 76045-004-01; Unit of Sale NDC Number 76045-004-11",
"product_quantity": "625500 syringes",
"product_type": "Drugs",
"reason_for_recall": "Labeling: Label Mixup: MicroVault labeled as Morphine 2 mg/1 mL, contains a Prefilled Syringe of Dilaudid 0.5 mg/0.5 mL.",
"recall_initiation_date": "20260804",
"recall_number": "D-0788-2026",
"recalling_firm": "Fresenius Kabi USA, LLC",
"report_date": "20260826",
"state": "IL",
"status": "Ongoing",
"voluntary_mandated": "Voluntary: Firm initiated"
}
来源:openFDA 已分级药品召回执法报告 · api.fda.gov